Angiotensin II and alpha-adrenergic agonists inhibit rat liver adenylate cyclase.
D000067956:Adenylyl Cyclase Inhibitors; D000316:Adrenergic alpha-Agonists / Q000494:pharmacology*; D000317:Adrenergic alpha-Antagonists / Q000494:pharmacology; D000804:Angiotensin II / Q000494:pharmacology*; D000818:Animals; D002414:Cations, Monovalent; D002462:Cell Membrane / Q000201:enzymology; D004837:Epinephrine / Q000494:pharmacology*; D006160:Guanosine Triphosphate / Q000494:pharmacology; D007700:Kinetics; D008099:Liver / Q000201:enzymology*; D010643:Phenoxybenzamine / Q000494:pharmacology; D010646:Phentolamine / Q000494:pharmacology; D051381:Rats
D000067956:Adenylyl Cyclase Inhibitors; D000316:Adrenergic alpha-Agonists; D000317:Adrenergic alpha-Antagonists; D002414:Cations, Monovalent; D010643:Phenoxybenzamine; D000804:Angiotensin II; D006160:Guanosine Triphosphate; D004837:Epinephrine; D010646:Phentolamine